A bladder spasm, also known as detrusor hyperreflexia, occurs when the bladder muscle squeezes involuntarily without warning. In addition to pain or discomfort, the spasms can lead to bladder leakage ...

French biotech tart-up EG 427 has successfully closed a 27 million-euro ($28.4 million) Series B financing round co-led by ...

Paris, France, February 20, 2025 – EG 427, a biotechnology company leading the development of pinpoint genetic medicines for prevalent chronic diseases in neurology, announced today the successful ...

intravesical pressure and the presence or absence of bladder sphincter dyssynergia and bladder hyperactivity. The treatment of neurogenic bladder dysfunction may be clinical or surgical and its ...

CereVasc has reported positive initial results in a pilot study of its eShunt System implant in treating elderly patients with normal pressure hydrocephalus (NPH). At the 90-day primary endpoint of ...

With the advancement in endoscopic surgery, radiation treatment planning and execution, as well as the use of new chemotherapeutic regimens, bladder conservation has evolved into a competing ...

These include medications, urinary tract infections, interstitial cystitis, and bladder cancer. Though the treatment can vary ... such as rare cases of non-neurogenic OAB in which therapeutic ...

Or you might have trouble after surgery if you develop a common condition called neurogenic bladder, which interferes with your nerve signals from the bladder to the brain. This makes it difficult ...

Bladder cancer symptoms can vary and may include painful urination and blood in your urine. Treatment options depend on how advanced the cancer is. Depending on the type of bladder cancer ...

In addition to the aNSCs themselves, adult neurogenesis is also regulated by the local environment, i.e., the neurogenic niche. Neurogenic niche is mainly composed ... in deep space exploration and to ...

A French biotech fo­cused on de­vel­op­ing ge­net­ic med­i­cines for neu­ro­log­i­cal con­di­tions has se­cured €27 mil­lion in a Se­ries B raise to sup­port its lead pro­gram … ...